» Articles » PMID: 19700394

Synovial Immunopathological Changes Associated with Successful Abatacept Therapy in a Case of Severe Refractory Psoriatic Arthritis

Overview
Journal Ann Rheum Dis
Specialty Rheumatology
Date 2009 Aug 25
PMID 19700394
Citations 9
Authors
Affiliations
Soon will be listed here.
Citing Articles

CTLA4-Ig treatment induces M1-M2 shift in cultured monocyte-derived macrophages from healthy subjects and rheumatoid arthritis patients.

Cutolo M, Soldano S, Gotelli E, Montagna P, Campitiello R, Paolino S Arthritis Res Ther. 2021; 23(1):306.

PMID: 34952630 PMC: 8709961. DOI: 10.1186/s13075-021-02691-9.


Abatacept reduces synovial regulatory T-cell expression in patients with psoriatic arthritis.

Szentpetery A, Heffernan E, Gogarty M, Mellerick L, McCormack J, Haroon M Arthritis Res Ther. 2017; 19(1):158.

PMID: 28679449 PMC: 5498994. DOI: 10.1186/s13075-017-1364-3.


Abatacept in psoriatic arthritis: Case report and short review.

Ursini F, Naty S, Russo E, Grembiale R J Pharmacol Pharmacother. 2013; 4(Suppl 1):S29-32.

PMID: 24347977 PMC: 3853664. DOI: 10.4103/0976-500X.120943.


Macrophages in synovial inflammation.

Kennedy A, Fearon U, Veale D, Godson C Front Immunol. 2012; 2:52.

PMID: 22566842 PMC: 3342259. DOI: 10.3389/fimmu.2011.00052.


Intimal lining layer macrophages but not synovial sublining macrophages display an IL-10 polarized-like phenotype in chronic synovitis.

Ambarus C, Noordenbos T, de Hair M, Tak P, Baeten D Arthritis Res Ther. 2012; 14(2):R74.

PMID: 22494514 PMC: 3446447. DOI: 10.1186/ar3796.